Anna Waszkiewicz

469 total citations
5 papers, 56 citations indexed

About

Anna Waszkiewicz is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anna Waszkiewicz has authored 5 papers receiving a total of 56 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anna Waszkiewicz's work include Tryptophan and brain disorders (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Protein Degradation and Inhibitors (2 papers). Anna Waszkiewicz is often cited by papers focused on Tryptophan and brain disorders (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Protein Degradation and Inhibitors (2 papers). Anna Waszkiewicz collaborates with scholars based in United States, Denmark and Canada. Anna Waszkiewicz's co-authors include Dean E. McNulty, William G. Bonnette, Dai‐Shi Su, Raman P. Nagarajan, Roland S. Annan, Liping Wang, Thau Ho, Amy Quinn, Caretha L. Creasy and Marc A. Holbert and has published in prestigious journals such as Pharmacological Research, Molecular and Cellular Biochemistry and SLAS DISCOVERY.

In The Last Decade

Anna Waszkiewicz

5 papers receiving 54 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Waszkiewicz United States	4	33	18	10	7	6	5	56
Anastasia Shneyderman Hong Kong	4	53 1.6×	30 1.7×		2 0.3×	11 1.8×	7	90
Jacob K. Asiedu United States	3	33 1.0×	16 0.9×		2 0.3×	7 1.2×	4	60
Jennifer Piesvaux United States	4	62 1.9×	16 0.9×		14 2.0×	4 0.7×	5	85
Isaac Joseph United States	3	53 1.6×	6 0.3×	1 0.1×	8 1.1×	5 0.8×	3	71
Cheng-Guo Wu United States	6	69 2.1×	11 0.6×	3 0.3×			8	99
Ruicheng Yang China	5	55 1.7×	43 2.4×	1 0.1×	14 2.0×	5 0.8×	5	89
Christian Schellhaas Switzerland	4	76 2.3×	13 0.7×		17 2.4×		5	101
Chris P. Doe Spain	3	25 0.8×	2 0.1×	2 0.2×	6 0.9×	2 0.3×	3	67
Yasaman Barekatain United States	5	23 0.7×	4 0.2×		4 0.6×	6 1.0×	8	48
David Wholley United States	3	11 0.3×	4 0.2×	5 0.5×		2 0.3×	3	69

Countries citing papers authored by Anna Waszkiewicz

Since Specialization

Citations

This map shows the geographic impact of Anna Waszkiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Waszkiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Waszkiewicz more than expected).

Fields of papers citing papers by Anna Waszkiewicz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Waszkiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Waszkiewicz. The network helps show where Anna Waszkiewicz may publish in the future.

Co-authorship network of co-authors of Anna Waszkiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Waszkiewicz. A scholar is included among the top collaborators of Anna Waszkiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Waszkiewicz. Anna Waszkiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Silva, Nicole Rodrigues da, Adriano José Maia Chaves Filho, Melina Mottin, et al.. (2024). Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression. Pharmacological Research. 211. 107545–107545. 3 indexed citations

2.

Bærentzen, Simone Larsen, et al.. (2024). A single subanaesthetic dose of the rapid-acting antidepressant S-ketamine raises presynaptic SV2A density in limbic regions of the Wistar Kyoto rat model of depression. Neuroscience Applied. 3. 104079–104079. 2 indexed citations

3.

Kallal, Lorena A., Anna Waszkiewicz, Anthony Della Pietra, et al.. (2021). High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells. SLAS DISCOVERY. 26(2). 216–229. 5 indexed citations

4.

McNulty, Dean E., William G. Bonnette, Hongwei Qi, et al.. (2017). A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1. SLAS DISCOVERY. 23(1). 34–46. 33 indexed citations

5.

Lewko, Barbara, Anna Waszkiewicz, Agnieszka Daca, et al.. (2015). Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes. Molecular and Cellular Biochemistry. 409(1-2). 243–253. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact